Trials / Completed
CompletedNCT02704091
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomized, Double Blind Placebo Controlled, Parallel, Groups Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 858 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate that diosmectite efficacy is superior to placebo regarding time to recovery of an acute diarrhoea episode presumed of infectious origin in adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Smecta | |
| DRUG | Smecta placebo |
Timeline
- Start date
- 2016-03-17
- Primary completion
- 2019-04-08
- Completion
- 2019-04-08
- First posted
- 2016-03-09
- Last updated
- 2020-11-05
- Results posted
- 2020-04-24
Locations
71 sites across 6 countries: Algeria, Czechia, Egypt, Lebanon, Poland, Tunisia
Source: ClinicalTrials.gov record NCT02704091. Inclusion in this directory is not an endorsement.